| Financial Year |
March 31 2023 |
| Monetary Funds |
19,743,290.75 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
22,913,791.31 |
| Accounts Receivable |
420,117,277.90 |
| Advances to Suppliers |
25,614,987.09 |
| Other Receivables |
27,978,964.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
612,158,741.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,819,993.09 |
| Total Current Assets |
1,147,180,455.82 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
23,751,983.87 |
| Fixed Assetes |
38,400,643.41 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
21,702,152.30 |
| R&D expenses |
-- |
| Goodwill |
42,630,874.93 |
| Long-Term Deferred and Prepaid Expenses |
1,313,352.92 |
| Deferred Income Tax Assets |
5,571,941.01 |
| Other Non-Current Assets |
1,874,884.06 |
| Sub-Total of Non-Current Assets |
141,517,805.40 |
| Total Assets |
1,288,698,261.22 |
| Short-Term Loans |
173,798,044.23 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
313,526,742.46 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
38,319,430.73 |
| Taxes Payable |
2,410,150.77 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
43,967,286.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
720,236.62 |
| Other Current Liabilities |
25,897,285.76 |
| Sub-Total of Current Liabilities |
931,851,277.26 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
11,943,096.75 |
| Deferred Income Tax Liabilities |
2,269,336.40 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
16,336,771.04 |
| Total Liabilities |
948,188,048.30 |
| Paid-In Capital(Or Share Stock) |
143,313,207.00 |
| Capital Surplus |
451,712,558.42 |
| Surplus Reserve |
34,623,416.72 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-305,913,989.19 |
| Minority Stockholder's Interest |
-7,243,559.22 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
347,753,772.14 |
| Owner's Equity（Stockholder's Equity） |
340,510,212.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,288,698,261.22 |
